| Robin Meredith Greenberg, DPT | |
|
5700 W Genesee St, Suite 2s, Camillus, NY 13031-3200 | |
| (315) 468-1050 | |
| (315) 468-1201 |
| Full Name | Robin Meredith Greenberg |
|---|---|
| Gender | Female |
| Speciality | Physical Therapist |
| Location | 5700 W Genesee St, Camillus, New York |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144695123 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 039628-1 (New York) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Robin Meredith Greenberg, DPT 5700 W Genesee St, Suite 2s, Camillus, NY 13031-3200 Ph: (315) 468-1050 | Robin Meredith Greenberg, DPT 5700 W Genesee St, Suite 2s, Camillus, NY 13031-3200 Ph: (315) 468-1050 |
News Archive
Blue Cross and Blue Shield of Minnesota and the American Cancer Society - High Plains Division have received CEO Cancer Gold Standard™ accreditation, recognizing the commitment of these organizations to reducing the risk of cancer for employees and their families by promoting healthy lifestyle choices, encouraging early detection through cancer screenings, and ensuring access to quality treatment.
A new study led by Dr. Robert Koenekoop at the Montreal Children's Hospital at the McGill University Health Centre holds promise for certain patients with Leber congenital amaurosis, an inherited retinal degenerative disease that causes significant vision loss from birth. The study, sponsored by Canadian company QLT Inc., is designed to treat patients with LCA due to genetic mutations in either retinal pigment epithelium protein 65 or lecithin:retinol acyltransferase.
Queen's University Brian Amsden is hoping that in about 10 years a tendon, spinal cord or heart valve will be able to regenerate itself after an injury or disease. The chemical engineering professor, along with scientists from the University of Western Ontario and University of Toronto, is currently trying to develop microscopic polymer fibers to help rebuild human tissue and speed the healing process.
Roche has announced that the European Commission has approved Avastin (bevacizumab, rhuMAb-VEGF), the new innovative anti-angiogenesis drug, for the treatment of patients with previously untreated metastatic colorectal cancer.
› Verified 5 days ago
Steve Rivizziano, PHYSICAL THERAPIST Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 4050 Milton Avenue, Camillus, NY 13031 Phone: 315-672-5063 Fax: 315-672-5461 | |
Mary Elizabeth Schmutz, PHYSICAL THERAPIST Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 5104 W Genesee St, Camillus, NY 13031 Phone: 315-569-0013 | |
Start Physical Therapy Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 5415 W Genesee St, Suite 101, Camillus, NY 13031 Phone: 315-487-8278 Fax: 315-487-8273 | |
Rebecca Mae Goal Carroll, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 5417 W Genesee St, Camillus, NY 13031 Phone: 315-418-4043 Fax: 315-469-1324 | |
Elizabeth Lynn Cullen, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 5700 W Genesee St Ste 2, Camillus, NY 13031 Phone: 315-468-1050 Fax: 315-468-1201 | |
Michael J Fiume, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 5320 W Genesee St, Suite 2, Camillus, NY 13031 Phone: 315-469-5400 Fax: 315-469-5724 |